LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 880

Search options

  1. Article ; Online: Selected updates on chronic obstructive pulmonary disease.

    Mah, Jordina / Ritchie, Andrew I / Finney, Lydia J

    Current opinion in pulmonary medicine

    2023  Volume 30, Issue 2, Page(s) 136–140

    Abstract: Purpose of review: Chronic obstructive pulmonary disease (COPD) is preventable disease and yet it remains the third greatest cause of death worldwide. This review focuses on recent updates in COPD research which have had an impact on our understanding ... ...

    Abstract Purpose of review: Chronic obstructive pulmonary disease (COPD) is preventable disease and yet it remains the third greatest cause of death worldwide. This review focuses on recent updates in COPD research which have had an impact on our understanding of the epidemiology and pathophysiology of COPD.
    Recent findings: Epidemiological studies of COPD have moved towards trying to understand the global impact of COPD particularly in low- and middle-income countries where disease prevalence continues to increase. In addition, we are beginning to uncover the impact of air pollution on COPD development with recent work showing a relationship between air pollution and COPD exacerbations. Advances in understanding early origins and early development of COPD have the potential to intervene earlier in the disease course to prevent disease progression. Although biomarkers such as peripheral blood eosinophilia have led to trials of biologic agents in COPD suggesting we may be entering an exciting new biologic era in COPD.
    Summary: Recent advances suggest there may be a relationship between air pollution and COPD exacerbations. This requires further research to influence environmental policy. New clinical trials of biologics targeting TH2 inflammation in COPD suggest that targeted treatments with biologics may be a possibility COPD.
    MeSH term(s) Humans ; Pulmonary Disease, Chronic Obstructive ; Disease Progression ; Air Pollution ; Inflammation/complications ; Biological Products/therapeutic use
    Chemical Substances Biological Products
    Language English
    Publishing date 2023-12-15
    Publishing country United States
    Document type Review ; Journal Article
    ZDB-ID 1285505-4
    ISSN 1531-6971 ; 1070-5287 ; 1078-1641
    ISSN (online) 1531-6971
    ISSN 1070-5287 ; 1078-1641
    DOI 10.1097/MCP.0000000000001042
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Metagenomic Characterization of the Respiratory Microbiome. A Pièce de Résistance.

    Ritchie, Andrew I / Singanayagam, Aran

    American journal of respiratory and critical care medicine

    2020  Volume 202, Issue 3, Page(s) 321–322

    MeSH term(s) Anti-Bacterial Agents ; Macrolides ; Metagenome ; Metagenomics ; Microbiota/genetics
    Chemical Substances Anti-Bacterial Agents ; Macrolides
    Language English
    Publishing date 2020-05-22
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202005-1686ED
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: The Challenges of Defining Early Chronic Obstructive Pulmonary Disease in the General Population.

    Ritchie, Andrew I / Martinez, Fernando J

    American journal of respiratory and critical care medicine

    2020  Volume 203, Issue 10, Page(s) 1209–1210

    MeSH term(s) Humans ; Pulmonary Disease, Chronic Obstructive/diagnosis ; Pulmonary Disease, Chronic Obstructive/epidemiology
    Language English
    Publishing date 2020-12-03
    Publishing country United States
    Document type Editorial ; Comment
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202011-4176ED
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Immunosuppression for hyperinflammation in COVID-19: a double-edged sword?

    Ritchie, Andrew I / Singanayagam, Aran

    Lancet (London, England)

    2020  Volume 395, Issue 10230, Page(s) 1111

    MeSH term(s) Betacoronavirus ; COVID-19 ; Coronavirus Infections ; Cytokines ; Heart Valve Diseases ; Humans ; Immunosuppression Therapy ; Inflammation ; Pandemics ; Pneumonia, Viral ; SARS-CoV-2
    Chemical Substances Cytokines
    Keywords covid19
    Language English
    Publishing date 2020-03-24
    Publishing country England
    Document type Letter ; Comment
    ZDB-ID 3306-6
    ISSN 1474-547X ; 0023-7507 ; 0140-6736
    ISSN (online) 1474-547X
    ISSN 0023-7507 ; 0140-6736
    DOI 10.1016/S0140-6736(20)30691-7
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. Article ; Online: Definition, Causes, Pathogenesis, and Consequences of Chronic Obstructive Pulmonary Disease Exacerbations.

    Ritchie, Andrew I / Wedzicha, Jadwiga A

    Clinics in chest medicine

    2020  Volume 41, Issue 3, Page(s) 421–438

    Abstract: Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are episodes of symptom worsening which have significant adverse consequences for patients. Exacerbations are highly heterogeneous events associated with increased airway and systemic ... ...

    Abstract Acute exacerbations of chronic obstructive pulmonary disease (AECOPD) are episodes of symptom worsening which have significant adverse consequences for patients. Exacerbations are highly heterogeneous events associated with increased airway and systemic inflammation and physiological changes. The frequency of exacerbations is associated with accelerated lung function decline, quality of life impairment and increased mortality. They are triggered predominantly by respiratory viruses and bacteria, which infect the lower airway and increase airway inflammation. A proportion of patients appear to be more susceptible to exacerbations, with poorer quality of life and more aggressive disease progression than those who have infrequent exacerbations. Exacerbations also contribute significantly to healthcare expenditure. Prevention and mitigation of exacerbations are therefore key goals of COPD management.
    MeSH term(s) Disease Progression ; Humans ; Pulmonary Disease, Chronic Obstructive/etiology ; Pulmonary Disease, Chronic Obstructive/pathology ; Pulmonary Disease, Chronic Obstructive/therapy ; Quality of Life/psychology
    Keywords covid19
    Language English
    Publishing date 2020-08-14
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 447455-7
    ISSN 1557-8216 ; 0272-5231
    ISSN (online) 1557-8216
    ISSN 0272-5231
    DOI 10.1016/j.ccm.2020.06.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Conservative versus Liberal Oxygen Therapy.

    Watson, Naomi / Brown, Elizabeth / Ritchie, Andrew I / Soni, Sanooj

    American journal of respiratory and critical care medicine

    2022  Volume 205, Issue 12, Page(s) 1470

    MeSH term(s) Humans ; Oxygen/therapeutic use ; Oxygen Inhalation Therapy
    Chemical Substances Oxygen (S88TT14065)
    Language English
    Publishing date 2022-05-02
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 1180953-x
    ISSN 1535-4970 ; 0003-0805 ; 1073-449X
    ISSN (online) 1535-4970
    ISSN 0003-0805 ; 1073-449X
    DOI 10.1164/rccm.202107-1609RR
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: The Effect of Inhaled Corticosteroids on Pneumonia Risk in Patients With COPD-Bronchiectasis Overlap: A UK Population-Based Case-Control Study.

    Ritchie, Andrew I / Singayagam, Aran / Mitchell, Sebastian / Wedzicha, Jadwiga A / Shah, Anand / Bloom, Chloë I

    Chest

    2023  Volume 164, Issue 4, Page(s) 875–884

    Abstract: Background: Inhaled corticosteroids (ICS) increase the risk of pneumonia in COPD and commonly are used in patients with COPD-bronchiectasis overlap.: Research question: Is the risk of pneumonia associated with ICS further heightened in COPD- ... ...

    Abstract Background: Inhaled corticosteroids (ICS) increase the risk of pneumonia in COPD and commonly are used in patients with COPD-bronchiectasis overlap.
    Research question: Is the risk of pneumonia associated with ICS further heightened in COPD-bronchiectasis?
    Study design and methods: Electronic health care records (from 2004-2019) were used to obtain a cohort of patients with COPD and a nested case-control group (age and sex matched 1:4). Analyses were conducted to determine the risk of hospitalization for pneumonia in COPD associated with ICS use in those with bronchiectasis. Findings were confirmed by several sensitivity analyses. Additionally, a smaller nested case-control group containing only patients with COPD-bronchiectasis overlap and those with recent blood eosinophil counts (BECs) was used to determine any association with BEC.
    Results: Three hundred sixteen thousand six hundred sixty-three patients were eligible for the COPD cohort; bronchiectasis significantly increased the risk of pneumonia (adjusted hazard ratio, 1.24; 95% CI, 1.15-1.33). In the first nested case-control group of 84,316 patients with COPD, ICS was found to increase the odds of pneumonia (adjusted OR [AOR], 1.26; 95% CI, 1.19-1.32) only if used in the previous 180 days. However, bronchiectasis was a significant modifier such that ICS use did not augment further the already elevated bronchiectasis-associated pneumonia risk (COPD-bronchiectasis: AOR, 1.01; 95% CI, 0.8-1.28; no bronchiectasis: AOR, 1.27; 95% CI, 1.20-1.34). Several sensitivity analyses and a second smaller nested case-control group confirmed these findings. Finally, we found that BEC modified the ICS-associated pneumonia risk in COPD-bronchiectasis overlap, where lower BEC was associated significantly with pneumonia (BEC ≤ 3 × 10
    Interpretation: ICS use does not augment further the already increased risk of hospitalization for pneumonia associated with concomitant bronchiectasis in patients with COPD.
    MeSH term(s) Humans ; Administration, Inhalation ; Bronchiectasis/complications ; Bronchiectasis/drug therapy ; Bronchiectasis/epidemiology ; Case-Control Studies ; Pneumonia/chemically induced ; Pneumonia/epidemiology ; Pneumonia/etiology ; Pulmonary Disease, Chronic Obstructive/complications ; Pulmonary Disease, Chronic Obstructive/drug therapy ; Pulmonary Disease, Chronic Obstructive/epidemiology ; United Kingdom/epidemiology ; Glucocorticoids/administration & dosage ; Glucocorticoids/adverse effects ; Glucocorticoids/therapeutic use ; Retrospective Studies ; England/epidemiology
    Chemical Substances Glucocorticoids
    Language English
    Publishing date 2023-06-17
    Publishing country United States
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 1032552-9
    ISSN 1931-3543 ; 0012-3692
    ISSN (online) 1931-3543
    ISSN 0012-3692
    DOI 10.1016/j.chest.2023.06.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article ; Online: Perceived influence of commercial milk formula labelling on mothers' feeding choices in Great Britain: a qualitative study.

    Conway, Rana / Ritchie, Isabel / Esser, Sara / Steptoe, Andrew / Smith, Andrea D / Llewellyn, Clare

    Archives of disease in childhood

    2023  Volume 108, Issue 12, Page(s) 1008–1013

    Abstract: Objective: To understand how mothers use commercial milk formula (CMF) labels to inform their feeding choices and explore mothers' understanding of differences between CMF products.: Design: Qualitative study with recruitment via social media. Online ...

    Abstract Objective: To understand how mothers use commercial milk formula (CMF) labels to inform their feeding choices and explore mothers' understanding of differences between CMF products.
    Design: Qualitative study with recruitment via social media. Online semistructured interviews, including a product mapping exercise and thematic analysis.
    Participants: Mothers (n=25) using CMF for children <3 years living in Great Britain (GB).
    Results: Mothers were drawn to brands they recognised from years of exposure to CMF advertising. CMF products were assumed to vary according to brand and stage, but participants found on-pack information did not explain how. This added to anxiety about choosing 'the best one' and mothers would have liked guidance from healthcare professionals (HCPs). Wide availability of CMF for older infants and children, and on-pack messaging suggesting progression from one product to the next, led many to believe these products were necessary. There was confusion over the appropriate use of specialist products. While mothers rarely mentioned on-pack health and nutrition claims, they were attracted to the overall appearance of packs and messaging relating to science, research and nature. References to breast milk and a logo perceived to represent a breastfeeding mother were taken as indicators of closer similarity to breast milk.
    Conclusions: CMF legislation in GB should be updated to restrict brand advertising and the use of on-pack text and images that mothers perceive as indicating products have a closer similarity to breast milk. Greater input from HCPs was desired by new mothers and would support them to make more informed choices about CMF.
    MeSH term(s) Infant ; Female ; Child ; Humans ; Breast Feeding ; Infant Formula ; United Kingdom ; Mothers ; Milk, Human
    Language English
    Publishing date 2023-08-04
    Publishing country England
    Document type Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 524-1
    ISSN 1468-2044 ; 0003-9888 ; 1359-2998
    ISSN (online) 1468-2044
    ISSN 0003-9888 ; 1359-2998
    DOI 10.1136/archdischild-2023-325767
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: In-situ TEM Deformation of High Entropy Alloys.

    Payne, Madelyn I / Zhang, Mingwei / Radmilović, Velimir R / Kumar, Punit / Asta, Mark / Ritchie, Robert O / Minor, Andrew M

    Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada

    2023  Volume 29, Issue Supplement_1, Page(s) 1518

    Language English
    Publishing date 2023-08-23
    Publishing country England
    Document type Journal Article
    ZDB-ID 1385710-1
    ISSN 1435-8115 ; 1431-9276
    ISSN (online) 1435-8115
    ISSN 1431-9276
    DOI 10.1093/micmic/ozad067.781
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top